Global ARDS literature analysis (2020-2025): a science mapping based bibliometric study

doi:10.3877/cma.j.issn.2096-1537.2025.04.007

Abstract

Abstract:

Objective

Based on the Web of Science database, a bibliometric analysis was conducted on global literature in the field of acute respiratory distress syndrome (ARDS) from 2020 to 2025 to explore the research landscape and hotspots in this domain.

Methods

Literature on ARDS from 2020 to 2025 indexed in the Web of Science database was retrieved. CiteSpace and VOSviewer were employed to analyze the publication countries, authors, institutions, and journals. Keyword cluster analysis was performed to identify research hotspots and themes.

Results

A total of 9271 articles were included. The United States contributed the highest number of publications (2792 articles), followed by China (2078 articles), Italy (1048 articles). The top three authors were Pelosi Paolo (78 articles), Marcus J. Schultz (65 articles), and Matthay Michael A (64 articles). The University of Toronto was the most prolific institution. Current research hotspots primarily included precise respiratory function assessment, ventilator-induced lung injury (VILI), subphenotypes, and risk prediction models.

Conclusion

Global research activity in the ARDS field has increased. Compared with European and American countries, China still lags in terms of publication volume, influential institutions, and highly cited authors. Future research will focus more on precise respiratory support strategies and subphenotype-based risk prediction models for ARDS patients.

Key words: ARDS, Bibliometric analysis, Research hotspots

Xuezhu Li, yan Wang, Hui Chen, Xiwen Zhang, Ling Liu, Xiaoqing Li, Yi Yang, Jianfeng Xie, Haibo Qiu. Global ARDS literature analysis (2020-2025): a science mapping based bibliometric study[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2025, 11(04): 368-379.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2025.04.007

https://icu.cma-cmc.com.cn/EN/Y2025/V11/I04/368

Figures/Tables 13

References 32

1	Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition [J]. JAMA, 2012, 307(23): 2526-2533.
2	Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome [J]. Nat Rev Dis Primers, 2019, 5(1): 18.
3	Papazian L, Calfee CS, Chiumello D, et al. Diagnostic workup for ARDS patients [J]. Intensive Care Med, 2016, 42(5): 674-685.
4	Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment [J]. Annu Rev Pathol, 2011, 6: 147-163.
5	Howell MD, Davis AM. Management of ARDS in adults [J]. JAMA, 2018, 319(7): 711-712.
6	Matthay MA. ECMO in severe acute respiratory distress syndrome [J]. Lancet Respir Med, 2019, 7(2): 106-108.
7	Chen C, Song M. Visualizing a field of research: a methodology of systematic scientometric reviews [J]. PLoS One, 2019, 14(10): e0223994.
8	高凯. 文献计量分析软件VOSviewer的应用研究 [J]. 科技情报开发与经济, 2015, 22(12): 95-98.
9	Chen CM, Ibekwe-sanjuan F, Hou JH. The structure and dynamics of co-citation clusters : a multiple-perspective co-citation analysis [J]. J Am Soc Inf Sci, 2010, 61(7): 1386-1409.
10	Zhang X, Wang C, Zhao H. A bibliometric analysis of acute respiratory distress syndrome (ARDS) research from 2010 to 2019 [J]. Ann Palliat Med, 2021, 10 (4): 3750-3762.
11	急性呼吸窘迫综合征精准分型诊治专家组. 急性呼吸窘迫综合征精准分型诊治专家共识 [J]. 中国临床医学, 2025, 32(4): 710-716.
12	中国研究型医院学会危重医学专委会, 宁波诺丁汉大学GRADE中心. 中国成人急性呼吸窘迫综合征 (ARDS)诊断与非机械通气治疗指南(2023) [J]. 中国研究型医院, 2023, 10(5): 9-24.
13	袁雪燕, 刘玲, 邱海波. 2023年欧洲重症医学学会与美国胸科协会急性呼吸窘迫综合征新指南之异同 [J]. 中国临床新医学, 2024, 17(2): 123-127．
14	王玉妹, 张琳琳, 周建新. ESICM急性呼吸窘迫综合征指南: 定义、表型和呼吸支持策略解读 [J]. 中国急救医学, 2023, 43 (11): 558-668.
15	Villar J, Ferrando C, Martinez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multi-center, randomised controlled trial [J]. Lancet Respir Med, 2020, 8(3): 267-276.
16	Ranieri VM, Pettila V, Karvonen MK, et al. Effect of intravenous interferon β-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: a randomized clinical trial [J]. JAMA, 2020, 323(8): 725-733.
17	Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome [J]. N Engl J Med, 2000, 342(18): 1301-1308.
18	Matthay MA, Arabi YM, Siegel ER, et al. Phenotypes and personalized medicine in the acute respiratory distress syndrome [J]. Intensive Care Med, 2020, 46(12): 2136‐2152.
19	Faust H, Mangalmurti NS. Collateral damage: necroptosis in the development of lung injury [J]. Am J Physiol Lung Cell Mol Physiol, 2020, 318(2): 215‐225.
20	Silva JD, de Castro LL, Braga CL, et al. Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology [J]. Stem Cells Int, 2019, 2019: 826-849.
21	Huang KY, Hung WC, Lin SC, et al. Influence of Liriodendrin on NLRP3-mediated pyroptosis and proinflammatory pathways in mice experiencing acute respiratory distress syndrome induced by lipopolysaccharide [J]. Biocell, 2025, 49(2): 315-334.
22	Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID- 19 are similar to other causes of ARDS [J]. Intensive Care Med, 2020, 46(12): 2200-2211.
23	European Respiratory Society. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure [J]. Eur Respir J, 2023, 61(5): 2204567.
24	Di Fenza R, Shetty NS, Gianni S, et al. High-dose inhaled Nitric Oxide in acute hypoxemic respiratory failure due to COVID-19: a multicenter phase Ⅱ trial [J]. Am J Respir Crit Care Med, 2023, 208(12): 1293-1304.
25	Sinha P, Delucchi KL, Chen Y, et al. Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study [J]. Thorax, 2022, 77(1): 13-21.
26	Villar J, González-Martín JM, Hernández-González J, et al. Predicting outcome and stratification of severity in ARDS (POSTCARDS) network. Predicting ICU mortality in acute respiratory distress syndrome patients using machine learning: the predicting outcome and stratification of severity in ARDS (POSTCARDS) Study [J]. Crit Care Med, 2023, 51(12): 1638-1649.
27	Wang W, Lei W, Jiang L, et al. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for COVID-19 treatment [J]. J Transl Med, 2021, 19(1): 198.
28	Mikolka P, Kosutova P, Kolomaznik M, et al. The synthetic surfactant CHF5633 restores lung function and lung architecture in severe acute respiratory distress syndrome in adult rabbits [J]. Lung, 2024, 202: 299-315.
29	Patel J, Bass D, Beishuizen A, et al. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR) [J]. Eur Respir J, 2023, 61(2): 2101870.
30	Herridge MS, Moss M, Hough CL, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers [J]. Intensive Care Med, 2016, 42(5): 725-738.
31	Prescott HC, Osterholzer JJ, Langa KM, et al. Long-term healthcare utilization and costs among survivors of acute respiratory distress syndrome: a population-based cohort study [J]. Crit Care Med, 2023, 51(5): e109-e118.
32	Pham T, Rubenfeld GD, Schmidt M, et al. The long-term outcome of patients with acute respiratory distress syndrome: the LUNG SAFE Study [J]. Am J Respir Crit Care Med, 2023, 207(12): 1585-1596.

序号	国家	发文量（篇）	被引频次	篇均被引频次
1	美国	2792	95 117	34.07
2	中国	2078	119 297	57.35
3	意大利	1048	42 302	40.36
4	法国	725	28 911	39.88
5	德国	718	26 927	37.50
6	英国	602	36 501	60.63
7	加拿大	501	24 653	49.21
8	西班牙	437	14 781	33.82
9	巴西	352	14 460	41.08
10	荷兰	336	18 753	55.81

序号	国家	发文量（篇）	被引频次	篇均被引频次
1	美国	2792	95 117	34.07
2	中国	2078	119 297	57.35
3	意大利	1048	42 302	40.36
4	法国	725	28 911	39.88
5	德国	718	26 927	37.50
6	英国	602	36 501	60.63
7	加拿大	501	24 653	49.21
8	西班牙	437	14 781	33.82
9	巴西	352	14 460	41.08
10	荷兰	336	18 753	55.81

序号	作者	发文量（篇）	被引频次	总链接强度
1	Pelosi Paolo	78	1795	5168
2	Marcus J. Schultz	65	1281	3508
3	Michael A. Matthay	64	1619	4413
4	Calfee，Carolyn S	63	4245	6514
5	Alain Combes	59	3091	6574
6	Fan，Eddy	54	5519	6145
7	Rocco，Patricia RM	53	1188	3989
8	Laffey，John G	51	1298	2670
9	Brodie，Daniel	48	3349	5689
10	Bellani，Giacomo	44	1544	3687

序号	作者	发文量（篇）	被引频次	总链接强度
1	Pelosi Paolo	78	1795	5168
2	Marcus J. Schultz	65	1281	3508
3	Michael A. Matthay	64	1619	4413
4	Calfee，Carolyn S	63	4245	6514
5	Alain Combes	59	3091	6574
6	Fan，Eddy	54	5519	6145
7	Rocco，Patricia RM	53	1188	3989
8	Laffey，John G	51	1298	2670
9	Brodie，Daniel	48	3349	5689
10	Bellani，Giacomo	44	1544	3687

排序	研究机构	国家	发文量（篇）	被引频次	总链接强度
1	多伦多大学	加拿大	220	7826	993 898
2	哈佛医学院	美国	195	11 192	645 639
3	米兰大学	意大利	151	4889	549 728
4	加州大学旧金山分校	美国	147	7289	708 192
4	宾夕法尼亚大学	美国	147	5024	530 766
5	索邦大学	法国	135	3952	537 139
6	华中科技大学	中国	129	40 826	322 814
7	密歇根大学	美国	117	6177	411 481
8	复旦大学	中国	108	7625	230 642
8	上海交通大学	中国	108	17 373	241 385
8	范德堡大学	美国	108	2525	440 391
9	约翰斯·霍普金斯大学	美国	107	2568	281 173
10	重庆医科大学	中国	106	1460	248 394

Please choose a citation manager

Content to export